Annual Meeting

What indirectly links brain disease to COVID-19?

Meet a JBC Herbert Tabor Early Career Investigator Award winner
Jessica Desamero
March 22, 2022

Armin Bayati’s undergraduate years cemented his dual fascination with biology and the brain. 

Bayati earned a bachelor’s degree in biology and psychology with distinction at the University of Victoria in British Columbia, where he worked at a medical sciences lab and started doing electron microscopy, a technique used to capture high-resolution images of a variety of specimens, such as cells and biopsy samples. He became intrigued by cellular functions and structures.

Armin Bayati
Armin Bayati

At the same time, Bayati worked at Saint Joseph’s Hospital as an activity coordinator for patients with a variety of disorders, the most common symptom being dementia. Witnessing the cognitive decline of patients with nervous system disorders got him interested in neuroscience. “A lot of what affects the elderly’s independence is neurological disorders, such as dementia, Alzheimer’s, or movement disorders like Parkinson’s and Huntington’s disease,” he said. “So that’s where my interest in the neurological aspects of things comes in.” 

These experiences led Bayati to study the biological mechanisms behind neurodegenerative disorders at a cellular level. Now a Ph.D. candidate at the Montréal Neurological Institute and Hospital at McGill University, he works in Peter McPherson’s lab, where his research focuses on alpha-synuclein, a neuronal protein linked to Parkinson’s disease and other disorders. He investigates how the pathological form of alpha-synuclein is brought into cells and what type of endocytosis occurs.

Bayati recently has used his expertise in endocytosis to study the virus that causes COVID-19. “We were looking at how pathological alpha-synuclein enters the cell,” he said. “The problem with COVID was the same thing. How does the virus enter the cell? It would be the same kind of experiments as we’d do for looking at the internalization of alpha-synuclein, but then I applied it to finding how the spike protein enters the cell.”

Getting the spike protein into the cell

Understanding mechanisms of SARS-CoV-2 cellular entry is vital, as antiviral strategies targeting early stages of COVID-19 infection can be highly effective. Researchers know that the virus first uses its spike protein to interact with the cell’s surface by binding to the ACE2 receptor on the plasma membrane. Next, SARS-CoV-2 likely is brought into the cell, but it’s unclear how.

In a  study in the Journal of Biological Chemistry, researchers at McGill University found that SARS-CoV-2 enters the cell via clathrin-mediated endocytosis, where the scaffold protein clathrin aids in packaging material into vesicles. In this study, purified spike protein and altered lentivirus bearing spike protein were used. The internalization of the spike protein into cells was examined and quantified.

Studies with purified spike showed that spike protein rapidly entered cells expressing ACE2 via endocytosis. When drugs known to block clathrin-mediated endocytosis were introduced, or when the expression of clathrin heavy chain was reduced, the cellular uptake of spike decreased dramatically.

Bayati devised the assay for spike protein uptake, which the team initially had trouble getting to work. Ideally, a fluorescently labeled spike protein would be used, but due to COVID-19 closures and a scarcity of available spike proteins, this wasn’t possible. Bayati thought of using spike protein with a His6 epitope tag on it instead. With this, they were able to follow protein uptake using antibodies.

Enjoy reading ASBMB Today?

Become a member to receive the print edition monthly and the digital edition weekly.

Learn more
Jessica Desamero

Jessica Desamero is a graduate student in the City University of New York’s biochemistry Ph.D. program and volunteers with two science outreach organizations, BioBus and World Science Festival.

Get the latest from ASBMB Today

Enter your email address, and we’ll send you a weekly email with recent articles, interviews and more.

Latest in People

People highlights or most popular articles

ASCB honors Asai, Goley and Bagde
Member News

ASCB honors Asai, Goley and Bagde

Dec. 5, 2022

These three ASBMB members have won recognition from the American Society for Cell Biology.

ASBMB delegates leave their mark on policymaking
Feature

ASBMB delegates leave their mark on policymaking

Dec. 1, 2022

Advocacy Training Program participants use their new skills to improve their institutional environments, create new programs, draft policy recommendations, perform targeted outreach and more.

2022 Sewer scholarship winners announced
Society News

2022 Sewer scholarship winners announced

Nov. 28, 2022

The $2,000 award goes to undergraduates who demonstrate an interest in the fields of biochemistry and molecular biology and enhance the diversity of science.

Brought to you (mostly) by and for women
Annual Meeting

Brought to you (mostly) by and for women

Nov. 23, 2022

The ASBMB’s Women in Biochemistry and Molecular Biology Committee has big plans for Discover BMB 2023.

Dedicated to sharing science
Student Chapters

Dedicated to sharing science

Nov. 21, 2022

Introduced to scientific research through her Tufts University ASBMB Student Chapter, Lema Abuoqab works to make sure other students can have the same experience.

Tolbert named HHMI VP; new phase for Hannun
Member News

Tolbert named HHMI VP; new phase for Hannun

Nov. 21, 2022

Awards, promotions, milestones and more. Find out what's going on in the lives of ASBMB members.